The existing vaccine paradigm assumes that vaccines only protect against the target
infection, that effective vaccines reduce mortality corresponding to the target infection's …

Contrary to the long-held belief that the effects of vaccines are specific for the disease they
were created; compelling evidence has demonstrated that vaccines can exert positive or …

Background A recent WHO review concluded that live BCG and measles vaccine (MV) may
have beneficial non-specific effects (NSEs) reducing mortality from non-targeted diseases …

Objectives In previous work examining the etiology of cribra orbitalia (CO) and porotic
hyperostosis (PH) in a contemporary juvenile mortality sample, we noted that males had …

Background In addition to protecting against measles, measles vaccine (MV) may have
beneficial nonspecific effects. We tested the effect of an additional early MV on mortality and …

Abstract The World Health Organisation (WHO) has recently revised how adverse events
after immunization (AEFI) are classified. Only reactions that have previously been …

WHO’s malaria vaccine study represents a “serious breach of international ethical standards” |
The BMJ Skip to main content Intended for healthcare professionals Access provided by Google …

Background Whole-cell diphtheria–tetanus–pertussis (DTP) and oral polio vaccine (OPV)
were introduced to children in Guinea-Bissau in 1981. We previously reported that DTP in …

WHO’s rollout of malaria vaccine in Africa: can safety questions be answered after only 24
months? Page 1 WHO’s rollout of malaria vaccine in Africa: can safety questions be …

Background Global mortality estimates remain heavily dependent on household surveys in
low-and middle-income countries, where most under-five deaths occur. Few studies have …